Management of Barrett's esophagus and early esophageal cancer: update on endoscopic treatment strategies.

[esophageal adenocarcinoma]

Barrett 's esophagus represents the strongest known risk factor for developing esophageal adenocarcinoma . The traditional management strategy for identifying and managing Barrett 's esophagus involves screening and endoscopic surveillance to identify early stage , curable carcinoma . Recently , endoscopic eradication therapy has emerged to achieve the complete eradication of Barrett 's esophagus and intramucosal cancer to prevent the development of invasive cancer with lymphatic spread . Randomized trials have demonstrated the efficacy of these approaches to reduce the progression to cancer , and endoscopic eradication therapy has become the preferred treatment approach for patients with high --grade dysplasia , and may be utilized for management of low --grade dysplasia as well . Owing to excellent eradication rates and favorable side effect profile , radio frequency ablation has emerged as the ablative strategy of choice for patients undergoing endoscopic eradication therapy .

Diseases
Validation

Diseases presenting "early stage" symptom

adrenomyeloneuropathy

allergic bronchopulmonary aspergillosis

aromatase deficiency

cadasil

carcinoma of the gallbladder

child syndrome

cholangiocarcinoma

congenital adrenal hyperplasia

esophageal adenocarcinoma

esophageal carcinoma

esophageal squamous cell carcinoma

familial hypocalciuric hypercalcemia

familial mediterranean fever

gm1 gangliosidosis

harlequin ichthyosis

hereditary cerebral hemorrhage with amyloidosis

hodgkin lymphoma, classical

kindler syndrome

lymphangioleiomyomatosis

neonatal adrenoleukodystrophy

pyomyositis

scrub typhus

sneddon syndrome

typhoid

von hippel-lindau disease

zellweger syndrome

You can validate or delete this automatically detected symptom